Juevesano, Jesus L.

HRN: 27-50-67  Sex: Male

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
08/14/2025
CEFTAZIDIME 1GM (VIAL)
08/13/2025
09/11/2025
IV
2g
Q8
CAP HR
Checking Initial Appropriateness 

 Indication:  Empirical Escalation    Type of Infection:  Pneumonia    Compliance to guidelines: Compliant To Guidelines